ALC
Alcon Inc
$66.87
-1.46 (-2.14%)
At close · Jul 7
Market Cap
$32.61B
Shares
487,700,000
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$66.87
Open$68.80
Day$65.99–69.00
52W$61.84–92.55
Avg vol 30d1.9M
Short int8.6M · 1.8% float · 5.0d
Short vol66%
Last earningsMay 6, 2026
DataJan 2020–Jul 2026
Equibles Rating
blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical
Neutral
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Excellent
Quant / Vol
Moderate
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−11%
below
Price vs 50-day avg
−1%
below
RSI (14)
49
neutral
MACD trend
Positive
52-week position
16%
mid-range
Momentum
relative strength
1-month return
0%
trailing
6-month return
−17%
trailing
YTD return
−15%
this year
Relative strength
−25%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $67 › 200d $75 — 200d above 50d
Institutional flow
Distributing
20 of 654 funds reported for Jun 30 · net -20.2K sh shares · +2 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
1.77% of float · ▲ +52.9% MoM · 5.0 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Multi-yr high
654 holders — near 3-yr high, broad support
Squeeze score
49
elevated · 0–100
Fundamentals
EPS growth
+9%
Y/Y
Free cash flow
$2.1B
Buyback
$750.0M
authorized
Balance sheet
$2.5B
net cash
Quant / Vol
risk profile
Volatility
29%
annualized · 1-yr
Max drawdown
−33%
past year
ATR
2.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
Next earnings call
Aug 5, 2026
Est · unconfirmed
· in 4 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−11%
Bearish
Price vs 50-day avg
−1%
Neutral
RSI (14)
49
Neutral
MACD trend
Positive
Bullish
52-week position
16%
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $67 › 200d $75 — 200d above 50d
Institutional flow
Distributing
20 of 654 funds reported for Jun 30 · net -20.2K sh shares · +2 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
1.77% of float · ▲ +52.9% MoM · 5.0 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Multi-yr high
654 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $62
Now $67 · 16%
52-wk high $93
vs 200-day avg -11%
vs 50-day avg -1%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Instruments & Supplies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ALC
this stock
Alcon Inc
|
$32.61B | -15.2% | — | — | 1.8% |
|
ISRG
Intuitive Surgical Inc
|
$147.01B | -24.6% | +20.5% | 50.4 | 2.2% |
|
MDLN
Medline Inc.
|
$52.94B | -4.0% | +11.5% | — | 2.1% |
|
BDX
Becton Dickinson & Co
|
$41.49B | +3.8% | +8.2% | 57.2 | 2.6% |
|
RMD
Resmed Inc
|
$31.88B | -8.6% | +13.4% | 21.2 | 8.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ALC | -0.9% | +0.1% | -17.3% | -0.3% | -15.2% |
| SPY | +0.9% | +1.4% | +7.6% | +0.1% | +9.7% |
| vs SPY | -1.8% | -1.3% | -24.9% | -0.5% | -24.8% |
Capital returns
Latest dividend
$0.358
/ share · ex May 5, 2026
Paid (TTM)
$0.358
/ share · 1 payout
Dividend yield (TTM, derived)
— · history filling in
Buyback program
· as of Feb 25, 2025
Authorized
$750.00M
Spent (derived)
—
Remaining
—
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
Key facts
CIK
1167379
CUSIP
H01301128
13F (30d)
22 filings
21 filers
Visit website
Investor relations